depomed inc (DEPO:NASDAQ GS)
Carl A. Pelzel
Former Chief Executive Officer, President and Director, DepoMed Inc.
|Age||Total Calculated Compensation||This person is connected to 0 board members in 0 different organizations across 3 different industries.|
Mr. Carl A. Pelzel served as the President and Chief Executive Officer of DepoMed Inc. since August 27, 2007 and also served as its Executive Vice President and Chief Operating Officer since September 27, 2005. Mr. Pelzel served as Vice President - Marketing and Commercial Development of Depomed Inc. since June 16, 2005. Mr. Pelzel, a proven biotechnology and pharmaceutical Executive, has over 28 years of experience in discovery, development and global commercialization ...
7999 Gateway BoulevardPhone: 510-744-8000
Newark, California 94560
Board Members Memberships*There is no Board Members Memberships data available.
Université de la Sorbonne - Université de Paris
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Ron Cohen M.D.||Founder, Chief Executive Officer, President and Director|
Acorda Therapeutics, Inc.
|Howard W. Robin||Chief Executive Officer, President and Director|
|Daniel J. Abdun-Nabi||Chief Executive Officer, President, Director, Member of Strategic Operations Committee and Member of Pricing Committee|
Emergent BioSolutions, Inc.
|Alessandro E. Della Chà LL.M||Chief Executive Officer and Director|
Cosmo Pharmaceuticals S.p.A.
|Michael L. Babich||Chief Executive Officer, President and Director|
INSYS Therapeutics, Inc.
|$889.2K||Compensation as of Fiscal Year 2014.|